ID   DLGP1_RAT               Reviewed;         992 AA.
AC   P97836; O54773; P97841;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   24-JUL-2024, entry version 169.
DE   RecName: Full=Disks large-associated protein 1 {ECO:0000305};
DE            Short=DAP-1;
DE   AltName: Full=Guanylate kinase-associated protein;
DE            Short=rGKAP {ECO:0000303|PubMed:27756895};
DE   AltName: Full=PSD-95/SAP90-binding protein 1;
DE   AltName: Full=SAP90/PSD-95-associated protein 1;
DE            Short=SAPAP1;
GN   Name=Dlgap1 {ECO:0000312|RGD:620223};
GN   Synonyms=Gkap {ECO:0000303|PubMed:27756895};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 4), AND INTERACTION WITH
RP   DLG1; DLG2; DLG3 AND DLG4.
RC   TISSUE=Brain;
RX   PubMed=9024696; DOI=10.1083/jcb.136.3.669;
RA   Kim E., Naisbitt S., Hsueh Y.-P., Rao A., Rothschild A., Craig A.M.,
RA   Sheng M.;
RT   "GKAP, a novel synaptic protein that interacts with the guanylate kinase-
RT   like domain of the PSD-95/SAP90 family of channel clustering molecules.";
RL   J. Cell Biol. 136:669-678(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 4; 5 AND 6), AND DEVELOPMENTAL
RP   STAGE.
RX   PubMed=9428732; DOI=10.1016/s0014-5793(97)01399-9;
RA   Kawashima N., Takamiya K., Sun J., Kitabatake A., Sobue K.;
RT   "Differential expression of isoforms of PSD-95 binding protein
RT   (GKAP/SAPAP1) during rat brain development.";
RL   FEBS Lett. 418:301-304(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9115257; DOI=10.1074/jbc.272.18.11943;
RA   Takeuchi M., Hata Y., Hirao K., Toyoda A., Irie M., Takai Y.;
RT   "SAPAPs. A family of PSD-95/SAP90-associated proteins localized at
RT   postsynaptic density.";
RL   J. Biol. Chem. 272:11943-11951(1997).
RN   [4]
RP   INTERACTION WITH BEGAIN AND DLG4.
RX   PubMed=9756850; DOI=10.1074/jbc.273.41.26269;
RA   Deguchi M., Hata Y., Takeuchi M., Ide N., Hirao K., Yao I., Irie M.,
RA   Toyoda A., Takai Y.;
RT   "BEGAIN (brain-enriched guanylate kinase-associated protein), a novel
RT   neuronal PSD-95/SAP90-binding protein.";
RL   J. Biol. Chem. 273:26269-26272(1998).
RN   [5]
RP   INTERACTION WITH DLG4 AND SHANK PROTEINS.
RX   PubMed=10527873; DOI=10.1006/bbrc.1999.1489;
RA   Boeckers T.M., Winter C., Smalla K.-H., Kreutz M.R., Bockmann J.,
RA   Seidenbecher C., Garner C.C., Gundelfinger E.D.;
RT   "Proline-rich synapse-associated proteins ProSAP1 and ProSAP2 interact with
RT   synaptic proteins of the SAPAP/GKAP family.";
RL   Biochem. Biophys. Res. Commun. 264:247-252(1999).
RN   [6]
RP   INTERACTION WITH DLG4 AND SHANK1.
RC   TISSUE=Brain;
RX   PubMed=10488079; DOI=10.1074/jbc.274.39.27463;
RA   Yao I., Hata Y., Hirao K., Deguchi M., Ide N., Takeuchi M., Takai Y.;
RT   "Synamon, a novel neuronal protein interacting with synapse-associated
RT   protein 90/postsynaptic density-95-associated protein.";
RL   J. Biol. Chem. 274:27463-27466(1999).
RN   [7]
RP   INTERACTION WITH SHANK PROTEINS, AND MUTAGENESIS OF THR-990; ARG-991 AND
RP   LEU-992.
RX   PubMed=10433268; DOI=10.1016/s0896-6273(00)80809-0;
RA   Naisbitt S., Kim E., Tu J.C., Xiao B., Sala C., Valtschanoff J.,
RA   Weinberg R.J., Worley P.F., Sheng M.;
RT   "Shank, a novel family of postsynaptic density proteins that binds to the
RT   NMDA receptor/PSD-95/GKAP complex and cortactin.";
RL   Neuron 23:569-582(1999).
RN   [8]
RP   INTERACTION WITH AIP1.
RX   PubMed=9694864; DOI=10.1074/jbc.273.33.21105;
RA   Hirao K., Hata Y., Ide N., Takeuchi M., Irie M., Yao I., Deguchi M.,
RA   Toyoda A., Suedhof T.C., Takai Y.;
RT   "A novel multiple PDZ domain-containing molecule interacting with N-methyl-
RT   d-aspartate receptors and neuronal cell adhesion proteins.";
RL   J. Biol. Chem. 273:21105-21110(1998).
RN   [9]
RP   INTERACTION WITH DYL2.
RX   PubMed=14760703; DOI=10.1002/pmic.200300528;
RA   Navarro-Lerida I., Martinez Moreno M., Roncal F., Gavilanes F., Albar J.P.,
RA   Rodriguez-Crespo I.;
RT   "Proteomic identification of brain proteins that interact with dynein light
RT   chain LC8.";
RL   Proteomics 4:339-346(2004).
RN   [10]
RP   INTERACTION WITH LRFN1.
RX   PubMed=16630835; DOI=10.1016/j.neuron.2006.04.005;
RA   Ko J., Kim S., Chung H.S., Kim K., Han K., Kim H., Jun H., Kaang B.-K.,
RA   Kim E.;
RT   "SALM synaptic cell adhesion-like molecules regulate the differentiation of
RT   excitatory synapses.";
RL   Neuron 50:233-245(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-362; SER-365; SER-389;
RP   SER-418; SER-421; SER-425; SER-428; SER-437; SER-509; SER-605; SER-608;
RP   SER-611 AND SER-947, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [12]
RP   INTERACTION WITH MPP2.
RX   PubMed=27756895; DOI=10.1038/srep35283;
RA   Rademacher N., Schmerl B., Lardong J.A., Wahl M.C., Shoichet S.A.;
RT   "MPP2 is a postsynaptic MAGUK scaffold protein that links SynCAM1 cell
RT   adhesion molecules to core components of the postsynaptic density.";
RL   Sci. Rep. 6:35283-35283(2016).
RN   [13]
RP   UBIQUITINATION BY TRIM3.
RX   PubMed=20352094; DOI=10.1371/journal.pone.0009842;
RA   Hung A.Y., Sung C.C., Brito I.L., Sheng M.;
RT   "Degradation of postsynaptic scaffold GKAP and regulation of dendritic
RT   spine morphology by the TRIM3 ubiquitin ligase in rat hippocampal
RT   neurons.";
RL   PLoS ONE 5:e9842-e9842(2010).
CC   -!- FUNCTION: Part of the postsynaptic scaffold in neuronal cells.
CC   -!- SUBUNIT: Interacts with guanylate kinase-like domain of DLG1, DLG2,
CC       DLG3, DLG4 and AIP1. Interacts with the PDZ domain of SHANK1, SHANK2
CC       and SHANK3. Found in a complex with DLG4 and SHANK1, SHANK2 or SHANK3.
CC       Found in a complex with DLG4 and BEGAIN. Interacts with DYL2 and LRFN1.
CC       Interacts with MPP2 (via the SH3-Guanylate kinase-like sub-module)
CC       (PubMed:27756895). {ECO:0000269|PubMed:10433268,
CC       ECO:0000269|PubMed:10488079, ECO:0000269|PubMed:10527873,
CC       ECO:0000269|PubMed:14760703, ECO:0000269|PubMed:16630835,
CC       ECO:0000269|PubMed:27756895, ECO:0000269|PubMed:9024696,
CC       ECO:0000269|PubMed:9694864, ECO:0000269|PubMed:9756850}.
CC   -!- INTERACTION:
CC       P97836; P31016: Dlg4; NbExp=9; IntAct=EBI-80901, EBI-375655;
CC       P97836; O88382: Magi2; NbExp=3; IntAct=EBI-80901, EBI-696179;
CC       P97836; Q9WV48: Shank1; NbExp=7; IntAct=EBI-80901, EBI-80909;
CC       P97836-5; Q9WV48: Shank1; NbExp=2; IntAct=EBI-6269434, EBI-80909;
CC       P97836-5; P78352: DLG4; Xeno; NbExp=3; IntAct=EBI-6269434, EBI-80389;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Peripheral membrane protein.
CC       Postsynaptic density. Synapse.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=SAPAP1;
CC         IsoId=P97836-1; Sequence=Displayed;
CC       Name=2; Synonyms=GKAP C, 2A;
CC         IsoId=P97836-4; Sequence=VSP_015415, VSP_015416;
CC       Name=3; Synonyms=GKAP A, GKAP1a;
CC         IsoId=P97836-5; Sequence=VSP_015415, VSP_015416, VSP_015420;
CC       Name=4; Synonyms=GKAP B, 2C;
CC         IsoId=P97836-6; Sequence=VSP_015415, VSP_015416, VSP_015419;
CC       Name=5; Synonyms=2B;
CC         IsoId=P97836-7; Sequence=VSP_015415, VSP_015418;
CC       Name=6; Synonyms=2D;
CC         IsoId=P97836-8; Sequence=VSP_015415, VSP_015417;
CC   -!- TISSUE SPECIFICITY: Expressed in brain and testis.
CC   -!- DEVELOPMENTAL STAGE: Highest level of isoform 1 in the brain of newborn
CC       rats. Increasing levels of isoforms 2, 3, 4, and 5 in the brain of
CC       newborn rats from birth to 6 weeks of postnatal development. Increasing
CC       but low level of isoform 6 is expressed in the brain from 2 to 6 weeks
CC       of postnatal development. {ECO:0000269|PubMed:9428732}.
CC   -!- PTM: Ubiquitinated by TRIM3; leading to proteasomal degradation.
CC       {ECO:0000269|PubMed:20352094}.
CC   -!- SIMILARITY: Belongs to the SAPAP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U67987; AAC53054.1; -; mRNA.
DR   EMBL; AB003594; BAA24265.1; -; mRNA.
DR   EMBL; U67137; AAB48587.1; -; mRNA.
DR   PIR; T00025; T00025.
DR   RefSeq; NP_001291216.1; NM_001304287.1. [P97836-7]
DR   RefSeq; XP_008765654.1; XM_008767432.2. [P97836-8]
DR   PDB; 4R0Y; X-ray; 2.00 A; A/B=807-916, A/B=946-971.
DR   PDB; 5OVC; X-ray; 1.55 A; B=987-992.
DR   PDBsum; 4R0Y; -.
DR   PDBsum; 5OVC; -.
DR   AlphaFoldDB; P97836; -.
DR   SMR; P97836; -.
DR   BioGRID; 249233; 9.
DR   CORUM; P97836; -.
DR   ELM; P97836; -.
DR   IntAct; P97836; 17.
DR   MINT; P97836; -.
DR   STRING; 10116.ENSRNOP00000073938; -.
DR   iPTMnet; P97836; -.
DR   PhosphoSitePlus; P97836; -.
DR   PaxDb; 10116-ENSRNOP00000022351; -.
DR   ABCD; P97836; 3 sequenced antibodies.
DR   Ensembl; ENSRNOT00000087592.2; ENSRNOP00000072852.1; ENSRNOG00000016196.8. [P97836-7]
DR   GeneID; 65040; -.
DR   KEGG; rno:65040; -.
DR   UCSC; RGD:620223; rat. [P97836-1]
DR   AGR; RGD:620223; -.
DR   CTD; 9229; -.
DR   RGD; 620223; Dlgap1.
DR   VEuPathDB; HostDB:ENSRNOG00000016196; -.
DR   eggNOG; KOG3971; Eukaryota.
DR   GeneTree; ENSGT00940000156220; -.
DR   InParanoid; P97836; -.
DR   PhylomeDB; P97836; -.
DR   Reactome; R-RNO-6794361; Neurexins and neuroligins.
DR   EvolutionaryTrace; P97836; -.
DR   PRO; PR:P97836; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Bgee; ENSRNOG00000016196; Expressed in frontal cortex and 14 other cell types or tissues.
DR   ExpressionAtlas; P97836; baseline and differential.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0014069; C:postsynaptic density; IDA:SynGO.
DR   GO; GO:0099092; C:postsynaptic density, intracellular component; IDA:SynGO.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:RGD.
DR   GO; GO:0099572; C:postsynaptic specialization; IBA:GO_Central.
DR   GO; GO:0045202; C:synapse; IDA:BHF-UCL.
DR   GO; GO:0060090; F:molecular adaptor activity; IBA:GO_Central.
DR   GO; GO:0019904; F:protein domain specific binding; IDA:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:UniProtKB.
DR   GO; GO:0098919; F:structural constituent of postsynaptic density; IDA:SynGO.
DR   GO; GO:0070842; P:aggresome assembly; IMP:BHF-UCL.
DR   GO; GO:0099562; P:maintenance of postsynaptic density structure; IC:SynGO.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; IDA:SynGO.
DR   GO; GO:0035418; P:protein localization to synapse; IMP:BHF-UCL.
DR   GO; GO:0061136; P:regulation of proteasomal protein catabolic process; IMP:BHF-UCL.
DR   GO; GO:0023052; P:signaling; IEA:InterPro.
DR   InterPro; IPR005026; SAPAP.
DR   PANTHER; PTHR12353:SF7; DISKS LARGE-ASSOCIATED PROTEIN 1; 1.
DR   PANTHER; PTHR12353; DISKS LARGE-ASSOCIATED PROTEIN DAP SAP90/PSD-95-ASSOCIATED PROTEIN; 1.
DR   Pfam; PF03359; GKAP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Membrane;
KW   Phosphoprotein; Reference proteome; Synapse; Ubl conjugation.
FT   CHAIN           1..992
FT                   /note="Disks large-associated protein 1"
FT                   /id="PRO_0000174290"
FT   REGION          154..209
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          355..375
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          665..676
FT                   /note="Interaction with DYL2"
FT                   /evidence="ECO:0000269|PubMed:14760703"
FT   REGION          687..698
FT                   /note="Interaction with DYL2"
FT                   /evidence="ECO:0000269|PubMed:14760703"
FT   REGION          914..980
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           990..992
FT                   /note="PDZ-binding"
FT   COMPBIAS        178..193
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        194..209
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        914..931
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        948..962
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         169
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D415"
FT   MOD_RES         362
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         365
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         368
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D415"
FT   MOD_RES         372
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D415"
FT   MOD_RES         389
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         418
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         421
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         425
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         428
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         437
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         509
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         516
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D415"
FT   MOD_RES         578
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D415"
FT   MOD_RES         579
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D415"
FT   MOD_RES         581
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D415"
FT   MOD_RES         605
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         606
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D415"
FT   MOD_RES         608
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         611
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         947
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         1..298
FT                   /note="Missing (in isoform 2, isoform 3, isoform 4, isoform
FT                   5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:9024696,
FT                   ECO:0000303|PubMed:9428732"
FT                   /id="VSP_015415"
FT   VAR_SEQ         299..325
FT                   /note="QKASVNMDQAVVKSEACQQERSCQYLQ -> MIDLFKAEWVSSVCVQVSRNG
FT                   RTDQVW (in isoform 2, isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:9024696,
FT                   ECO:0000303|PubMed:9428732"
FT                   /id="VSP_015416"
FT   VAR_SEQ         299..325
FT                   /note="QKASVNMDQAVVKSEACQQERSCQYLQ -> MNLIFHKDILFGVSATK (in
FT                   isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:9428732"
FT                   /id="VSP_015417"
FT   VAR_SEQ         299..324
FT                   /note="QKASVNMDQAVVKSEACQQERSCQYL -> MIDLFKAEWVSSVCVQVSRNGR
FT                   TD (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:9428732"
FT                   /id="VSP_015418"
FT   VAR_SEQ         537..546
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:9024696,
FT                   ECO:0000303|PubMed:9428732"
FT                   /id="VSP_015419"
FT   VAR_SEQ         547..574
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:9024696"
FT                   /id="VSP_015420"
FT   MUTAGEN         990
FT                   /note="T->A: Abolishes interaction with SHANK1."
FT                   /evidence="ECO:0000269|PubMed:10433268"
FT   MUTAGEN         991
FT                   /note="R->D: Abolishes interaction with SHANK1."
FT                   /evidence="ECO:0000269|PubMed:10433268"
FT   MUTAGEN         992
FT                   /note="L->A: Abolishes interaction with SHANK1."
FT                   /evidence="ECO:0000269|PubMed:10433268"
FT   CONFLICT        636
FT                   /note="S -> T (in Ref. 1; AAC53054 and 2; BAA24265)"
FT                   /evidence="ECO:0000305"
FT   HELIX           808..835
FT                   /evidence="ECO:0007829|PDB:4R0Y"
FT   HELIX           841..858
FT                   /evidence="ECO:0007829|PDB:4R0Y"
FT   HELIX           860..871
FT                   /evidence="ECO:0007829|PDB:4R0Y"
FT   HELIX           882..907
FT                   /evidence="ECO:0007829|PDB:4R0Y"
FT   STRAND          988..991
FT                   /evidence="ECO:0007829|PDB:5OVC"
SQ   SEQUENCE   992 AA;  110178 MW;  44BAF9BC0C14C099 CRC64;
     MKGLSGSRSH HHGITCESAC DSLSHHSDHK PYLLSPVDHH PADHPYYTQR NSFQAECVGP
     FSDPLASSTF PRRHYTSQQE LKDESALVPR TLATKANRLP TNLLDQFERQ LPLSRDGYHT
     LQYKRTAVEH RSDSPGRIRH LVHSVQKLFT KSHSLEGASK GGVNGGKASP DGSQTVRYGK
     RSKSKERRSE PKARSNASNA SPTSPSWWSS DDNLDGDMCL YHTPSGVMTM GRCPDRSVSQ
     YFMGAYNTIS EQAVKASRSN NDVKCSTCAN LPVTLDAPLL KKSAWSSTLT VSRAREVYQK
     ASVNMDQAVV KSEACQQERS CQYLQVPQDE WTGYTPRGKD DEIPCRRMRS GSYIKAMGDE
     DSGDSDTSPK PSPKVAARRE SYLKATQPSL TELTTLKISN EHSPKLQIRS HSYLRAVSEV
     SINRSLDSLD PAGLLTSPKF RSRNESYMRA MSTISQVSEM EVNGQFESVC ESVFSELESQ
     AVEALDLPMP GCFRMRSHSY VRAIEKGCSQ DDECVSLRSS SPPRTTTTVR TIQSSTGVIK
     LSSAVEVSSC ITTYKKTPPP VPPRTTTKPF ISITAQSSTE SAQDAYMDGQ GQRGDMISQS
     GLSNSTESLD SMKALTAAIE AANAQIHGPA SQHMGSNAAA VTTTTTIATV TTEDRKKDFK
     KNRCLSIGIQ VDDAEESEKM AESKTSSKFQ SVGVQVEEEK CFRRFTRSNS VTTAVQADLD
     FHDNLENSLE SIEDNSCPGP MARQFSRDAS TSTVSIQGSG NHYHACAADD DFDTDFDPSI
     LPPPDPWIDS ITEDPLEAVQ RSVCHRDGHW FLKLLQAERD RMEGWCKQME REERENNLPE
     DILGKIRTAV GSAQLLMAQK FYQFRELCEE NLNPNAHPRP TSQDLAGFWD MLQLSIENIS
     MKFDELHQLK ANNWKQMDPL DKKERRAPPP VPKKPAKGPA PLIRERSLES SQRQEARKRL
     MAAKRAASVR QNSATESAES IEIYIPEAQT RL
//
